Bemobile Intervention to Support Physical Activity in Cancer Survivors

April 15, 2019 updated by: Nancy Gell, University of Vermont

Bemobile: A Text Intervention to Support Physical Activity in Cancer Survivors

This study evaluates a technology based intervention (physical activity tracker, text messages, health coach, global positioning system enabled location based feedback on physical activity) to support physical activity in cancer survivors after completing oncology rehabilitation. In Phase 1 all participants received the full intervention. In phase II participants are randomly assigned to receive the full intervention or a fitbit only.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This intervention, offered to participants after completing oncology rehabilitation, integrates known preferences and determinants of physical activity participation in women and breast cancers survivors including social support, professional guidance, self-efficacy, goal setting, self-regulation, and environmental awareness delivered through accessible technology. For the iteration phase, the investigators will conduct an initial, abbreviated intervention wave lasting 4 weeks; the investigators will then incorporate participant input and feedback on the specific components to refine the intervention prior to a pilot trial. Means of delivering the components include communication and support through tailored text messaging, health coaching phone calls, self-monitoring of physical activity through a wearable sensor, and environmental assessment of community physical activity options (e.g., parks, fitness centers, trails) based on global positioning system information.

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Vermont
      • Burlington, Vermont, United States, 05405
        • University of Vermont

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

22 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Cancer diagnosis
  • Impending graduation from oncology rehabilitation

Exclusion Criteria:

  • Metastatic cancer
  • Concurrent radiation or chemotherapy
  • No cell phone
  • Inability to read or speak English.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Text Intervention
Participants receive text messages to a personal cell phone over 8 weeks, wear a fitbit to monitor physical activity, and communicate with a health coach intermittently over 2 weeks
Active Comparator: Active Control
Participants receive and wear a fitbit only for 8 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in Step counts
Time Frame: 8 weeks
Mean daily step counts as assessed by Actigraph Accelerometer
8 weeks
Change from Baseline in Moderate to Vigorous Physical Activity (MVPA)
Time Frame: 8 weeks
Weekly accumulated minutes spent in MVPA as assessed by Actigraph Accelerometer
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Weekly average of mean daily step counts
Time Frame: 8 weeks
Step counts assessed during the intervention with the Fitbit One
8 weeks
Change from Baseline in Self-efficacy to perform exercise
Time Frame: 8 weeks
Scale developed by Garcia and King
8 weeks
Change from Baseline in Self-regulation
Time Frame: 8 weeks
Scale Developed R. Umstattd
8 weeks
Change from Baseline in Fatigue
Time Frame: 8 weeks
Fatigue Symptom Inventory (FSI)
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2015

Primary Completion (Actual)

July 30, 2018

Study Completion (Actual)

November 1, 2018

Study Registration Dates

First Submitted

July 2, 2016

First Submitted That Met QC Criteria

July 6, 2016

First Posted (Estimate)

July 7, 2016

Study Record Updates

Last Update Posted (Actual)

April 17, 2019

Last Update Submitted That Met QC Criteria

April 15, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • CHRMS15-405
  • VCC1504 (Other Identifier: Vermont Cancer Center)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No plan to make individual participant data available

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Subscribe